← Open Payments lookup

STELLA NKWOCHA: Open Payments

NPI 1487296828 · BALTIMORE, MD. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,327 in 49 payments from 12 companies in 2025. Trend: 2023 $1,450 · 2024 $1,520 · 2025 $1,327

Food & beverage: $1,327
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.7$280
Supernus Pharmaceuticals, Inc.8$220
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)6$195
Alkermes, Inc.7$152
Otsuka America Pharmaceutical, Inc.4$104
Indivior Inc.3$87
E.R. Squibb & Sons, L.L.C.4$85
Teva Pharmaceuticals USA, Inc.3$72
Lundbeck LLC3$65
ABBVIE INC.2$36

Products named: INGREZZA, Qelbree, CAPLYTA, SUBLOCADE, COBENFY, ARISTADA, ABILIFY MAINTENA, UZEDY.

Industry payments across MD — which companies pay providers there.